Wednesday, June 10, 2026

Pyongyang Accuses U.S. of Turning South Korea Into Forward Base for Containing China

North Korea criticizes ROK-U.S. alliance, highlighting U.S. military strategies aimed at deterring China and raising regional tensions.

New Breakthrough Could Unlock the Secrets of Supermassive Black Holes

A significant breakthrough today in addressing the final parsec problem, which affects the formation of supermassive black holes.

Elbridge Colby in Seoul: Explaining the New U.S. Defense Strategy and What It Signals for OPCON

U.S. Deputy Assistant Secretary of Defense Elbridge Colby visits South Korea to discuss the National Defense Strategy and military cooperation.

Tag: Herzuma

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

Top News

- Our Sponsors Ad -

Follow us